Aster DM Healthcare Share Price Aster DM Health.
|Chairman & Managing Director||Mandayapurath Azad Moopen|
|Director||T J Wilson|
|Deputy Managing Director||Alisha Moopen|
|Director||Daniel Robert Mintz|
|Director||Shamsudheen Bin Mohideen Mammu Haji|
|Independent Director||Ravi Prasad|
|Independent Director||Daniel James Snyder|
|Independent Director||Suresh Muthukrishna Kumar|
|Company Secretary||Puja Aggarwal|
|Independent Director||BIJU VARKKEY|
|Independent Director||Layla Mohamed Hassan Ali Al Marzooqi|
|Addtnl Independent Director||Chenayappillil John George|
|Additional Director||James Mathew|
Aster DM Healthcare Limited is one of the largest private healthcare service providers, which operate in multiple GCC states, based on numbers of hospitals and clinics, according to the Frost & Sullivan Report, and an emerging healthcare player in India. The company has a strong presence across primary, secondary, tertiary and quaternary healthcare through its 20 hospitals, 112 clinics and 213 pharmacies. The Company conducts operations in all of the GCC states, which comprises the United Arab Emirates, Oman, Saudi Arabia, Qatar, KSA, Kuwait and Bahrain, in Jordan, India and the Philippines. The GCC operations are headquartered in Dubai, United Arab Emirates and its Indian operations are headquartered in Kochi, Kerala. As on 31st March 2018 the company has 9 subsidiaries and 48 stepdown subsidiaries and 4 associate companies. The Company operates in multiple segments of the healthcare industry, including hospitals, clinics and retail pharmacies and provides healthcare services to patients across economic segments in several GCC states through its various brands Aster, Medcare and Access. Aster and other brands of the company are widely recognised in the GCC states both by healthcare professionals and patients. The companys hospital network consists of 9 hospitals in GCC states and 11 multi-specialty hospitals and 9 clinics in India. Its hospitals in India are located in Kochi, Kolhapur, Kozhikode, Kottakkal, Bengaluru, Vijayawada, Guntur, Ongole, Wayanad and Hyderabad and are generally operated under the Aster, MIMS, Ramesh or Prime brands. The company has one of the largest and most widespread network of clinics across the Middle East. The Aster DM network has 112 clinics in total with 103 clinics in GCC states and 9 clinics in India. The company has the largest pharmacy chain in the GCC with 213 retail stores including 180 in UAE, 7, 12, 6, 6 and 2 in Kuwait, Jordan, Qatar, Oman and Bahrain respectively.The Company commenced operations in 1987 as a single doctor clinic in Dubai established by the founder, Dr. Azad Moopen. Its first specialty medical centre was launched in Dubai in 1995. The Companys MIMS, or Malabar Institute of Medical Sciences, hospital in Kozhikode, Kerala, India, commenced operations in 2001. In 2005, Al Rafa Hospital for Maternity and Surgery (now called Aster Day Surgery Centre LLC) commenced operations. In 2006, Medcare Hospital commenced operations.The Company was incorporated in January 18, 2008 as DM Healthcare Private Limited on January 18, 2008 at Kochi, Ernakulam, Kerala, in a reorganisation to facilitate the growth of its operations, subsequent to which operations in the GCC states and India were consolidated under the Company. In 2008, India Value Fund III A acquired 28.2% of the paid up Equity Share capital the company calculated at the time of investment. During the year under review, the company acquired majority stake in Prerana Hospital Limited (PHL), Kolhapur. In 2009, the companys Al Raffah Hospital located in Muscat, Oman, commenced operations. In 2010, the company acquired 100% of the paid up equity share capital of Affinity Holdings Private Limited, Mauritius. During the year under review, the companys second Al Raffah Hospital in Oman commenced operations in Sohar. In 2011, the companys second Medcare Hospital, namely Medcare Orthopedics and Spine Hospital (Dubai) commenced operations.In 2012, Olympus Capital Asia Investments Limited acquired 25.47% stake in the company. During the year under review, the company conditionally acquired 40.80% of the paid up equity share capital of Sanad Al Rahma for Medical Care LLC.In 2013, the company acquired 60.35% of the paid up equity share capital of Indogulf Hospitals Private Limited (IHPL) and consequently Malabar Institute of Medical Sciences Limited (MIMS) became a subsidiary of the company.The name of the company was changed to Aster DM Healthcare Private Limited and a fresh certificate of incorporation consequent upon change of name was issued on November 29, 2013.The company acquired hospital operational and management rights in Aster CMC, Bangalore pursuant to the hospital operation and management agreement dated May 12, 2014. In August 2014, the company launched Aster Medcity in Kochi, Kerala, a multi-speciality hospital with a 670 bed capacity, to be positioned as a destination for medical value travel.The company was converted into a public limited company consequent to a special resolution passed by our shareholders at the extraordinary general meeting held on November 10, 2014 and the name of our Company was changed to Aster DM Healthcare Limited.In 2014, the company acquired 51% voting rights in Sainatha Hospitals, Andhra Pradesh, 54% stake in Aster Kuwait for Medicine and Medical Supplied Company WLL and 51% stake in Orange Pharmacies LLC, Jordan. In 2015, the companys first clinic in the Kingdom of Bahrain and Philippines commenced operations. In 2016, the company divested its stake in Medipoint Hospitals Private Limited, Pune. During the year under review, the company increased stake up to 70.68% in the paid up equity share capital of MIMS. During the year under review, the company increased stake up to 97% stake in Sanad Medical Care. During the year under review, the company acquired 51% stake in Dr Ramesh Hospital. During the year under review, the companys second clinic in Bahrain commenced operations. During the year under review, the companys Medcare Women and Child Hospital in Dubai became operational. During the year under review, the company launched its first multi-specialty hospital in Sharjah.The company acquired hospital operational and management rights in DM Wayanad Institute of Medical Sciences, Wayanad pursuant to a medical services agreement and an operation and management agreement, both dated March 4, 2016.In 2017, the company entered into an operation and management agreement with the Rashtreeya Sikshana Samithi Trust to operate and manage a hospital in Bengaluru. During the year under review, the companys Medare Hospital Sharjah and Aster Hospital Doha commenced operations.On 14/08/2017 the company filed Draft Red Herring Prospectus and on 07/02/2018 filed Red Herring Prospectus with SEBI for raising Rs. 980.14 cr. The Issue dates were from 12/02/2018 to 15/02/2018 with Price Band of Rs. 180 to Rs. 190. The Issue got subscribed 1.18 times leading to its Issue Price being fixed at Rs. 190. The Shares got listed in BSE and NSE on 26/02/2018 at Rs. 182.10. which is 4.16% below Issue Price.On 9 April 2018, Aster DM Healthcare announced that it has entered into an agreement with Subramanya Constructions & Development Company Limited (SCDC), a leading real estate developer, to construct a new hospital in Chennai. This 500 bedded, state of the art, multi-specialty hospital is expected to commission in 2020. The hospital, which would be situated at a prime location in Chennai, will provide advanced healthcare services to the residents of Tamil Nadu and customers from other states in India as well as overseas.During the year 2018, Aster Ramesh Duhita LLP, Dr. Moopens Aster Hospital WLL, Harley Street Dental LLC and Aster DCC Pharmacy LLC have become subsidiaries of the Company.